These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10853217)

  • 1. Vasopressin effective in reversing catecholamine-resistant vasodilatory shock.
    Lim TW; Lee S; NG KS
    Anaesth Intensive Care; 2000 Jun; 28(3):313-7. PubMed ID: 10853217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
    Saab G; Mindel G; Ewald G; Vijayan A
    Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Cardiotonic Drugs in Neonates.
    Dempsey E; Rabe H
    Clin Perinatol; 2019 Jun; 46(2):273-290. PubMed ID: 31010560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of vasopressin to treat catecholamine-resistant hypotension after phaeochromocytoma removal.
    Tan SG; Koay CK; Chan ST
    Anaesth Intensive Care; 2002 Aug; 30(4):477-80. PubMed ID: 12180588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent.
    Argenziano M; Chen JM; Choudhri AF; Cullinane S; Garfein E; Weinberg AD; Smith CR; Rose EA; Landry DW; Oz MC
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):973-80. PubMed ID: 9832689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasopressin for treatment of shock].
    Carrillo-Esper R; Calvo-Carrillo B
    Cir Cir; 2003; 71(2):129-36. PubMed ID: 19764141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intraaortic balloon pumping.
    Moulopoulos SD; Stamateolopoulos SF; Nanas JN; Kontoyannis DA; Nanas SN
    Chest; 1993 Jan; 103(1):248-52. PubMed ID: 8417888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.
    Summaria F; Mustilli M; Sette A; Lanzillo C; Romagnoli E
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):28-31. PubMed ID: 24492986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest.
    Scroggin RD; Quandt J
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):145-57. PubMed ID: 19691565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 15. Vassopressors and inotropes.
    Med Lett Drugs Ther; 2011 Nov; 53(1377):90-2. PubMed ID: 22075670
    [No Abstract]   [Full Text] [Related]  

  • 16. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome?
    Dünser MW; Fries DR; Schobersberger W; Ulmer H; Wenzel V; Friesenecker B; Hasibeder WR; Mayr AJ
    Anesth Analg; 2004 Jul; 99(1):201-206. PubMed ID: 15281530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes.
    Udeh CI; Diaz-Gómez JL; Anthony D; Satyapriya A; Perez-Protto S; Hata JS
    Curr Pharm Des; 2012; 18(38):6308-13. PubMed ID: 22762470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
    Noori S; Seri I
    Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin in Vasodilatory Shock.
    Ukor IF; Walley KR
    Crit Care Clin; 2019 Apr; 35(2):247-261. PubMed ID: 30784607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.